IntelligentMDx

CAMBRIDGE, Mass., Jan. 7, 2013 /PRNewswire/ -- IntelligentMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use ... read more

CAMBRIDGE, Mass., Jan. 7, 2013 /PRNewswire/ -- IMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on ... read more

CAMBRIDGE, Mass., Dec. 19, 2012 /PRNewswire -- IntelligentMDx (IMDx) is pleased to announce that Maurice Exner, Ph.D., has joined IMDx as Vice President of Research and Development. (Logo: http://photos.prnewswire.com/prnh/20120306/NE63745LOGO ) Formerly serving as Vice President of R&D at Focus Diagnostics, a wholly owned subsidiary of Quest Diagnostics Incorporated, ... read more